Jason Oppenheimer: Final Debarment Order

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jason Oppenheimer for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Oppenheimer was convicted of one felony count under Federal law for the offense of possession with intent to distribute Tapentadol. The factual basis supporting Mr. Oppenheimer's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Oppenheimer was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of July 17, 2025 (30 days after receipt of the notice), Mr. Oppenheimer had not responded. Mr. Oppenheimer's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

Abstract as published in the Federal Register.

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.